Peter-Paul M Willemse
Overview
Explore the profile of Peter-Paul M Willemse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
2466
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flach R, van Dooijeweert C, Nguyen T, Lynch M, Jonges T, Meijer R, et al.
JCO Clin Cancer Inform
. 2025 Mar;
9:e2400193.
PMID: 40036728
Purpose: Pathologists diagnose prostate cancer (PCa) on hematoxylin and eosin (HE)-stained sections of prostate needle biopsies (PBx). Some laboratories use costly immunohistochemistry (IHC) for all cases to optimize workflow, often...
2.
Sakalis V, Bhattacharya Y, Beyer K, Murray C, Smith E, Willemse P, et al.
Eur Urol Open Sci
. 2024 Nov;
70:183-193.
PMID: 39611162
Background And Objective: Clinical practice guidelines for prostate cancer (PCa) are a valuable resource for everyday clinical practice. The clinical practice guidelines and recommendations produced by various societies should demonstrate...
3.
Tilki D, van den Bergh R, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al.
Eur Urol
. 2024 Apr;
86(2):164-182.
PMID: 38688773
Background And Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International...
4.
Cornford P, van den Bergh R, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al.
Eur Urol
. 2024 Apr;
86(2):148-163.
PMID: 38614820
Background And Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International...
5.
Rajwa P, Borkowetz A, Abbott T, Alberti A, Bjartell A, Brash J, et al.
Eur Urol Open Sci
. 2024 Apr;
63:81-88.
PMID: 38572301
Combination therapies in metastatic hormone-sensitive prostate cancer (mHSPC), which include the addition of an androgen receptor signaling inhibitor and/or docetaxel to androgen deprivation therapy, have been a game changer in...
6.
van Harten M, Roobol M, van Leeuwen P, Willemse P, van den Bergh R
BJU Int
. 2024 Mar;
134(1):31-42.
PMID: 38469728
Population-based organised repeated screening for prostate cancer has been found to reduce disease-specific mortality, but with substantial overdiagnosis leading to overtreatment. Although only very few countries have implemented a screening...
7.
Marra G, van Leenders G, Zattoni F, Kesch C, Rajwa P, Cornford P, et al.
Eur Urol
. 2023 Apr;
84(1):65-85.
PMID: 37117107
Context: The optimal management for men with prostate cancer (PCa) with unconventional histology (UH) is unknown. The outcome for these cancers might be worse than for conventional PCa and so...
8.
Reesink D, Arteaga de Castro C, Van der Velden T, van Vooren J, Oost P, Jonges T, et al.
NMR Biomed
. 2023 Apr;
36(10):e4958.
PMID: 37094995
Chemical exchange saturation transfer (CEST) has been explored for differentiation between tumour and benign tissue in prostate cancer (PCa) patients. With ultrahigh field strengths such as 7-T, the increase of...
9.
Mehra N, Kloots I, Vlaming M, Aluwini S, Dewulf E, Oprea-Lager D, et al.
Eur Urol Open Sci
. 2023 Mar;
49:23-31.
PMID: 36874601
Background: Germline and tumour genetic testing in prostate cancer (PCa) is becoming more broadly accepted, but testing indications and clinical consequences for carriers in each disease stage are not yet...
10.
Risk of osteoporosis in testicular germ cell tumour survivors: A systematic review of the literature
Vrouwe J, Hennus P, Hamdy N, Osanto S, Willemse P
BJUI Compass
. 2022 Dec;
4(1):24-43.
PMID: 36569500
Context: Testicular germ cell tumour (TGCT) survivors are potentially at risk of developing osteoporosis, because of increased risk for disturbed bone remodelling associated with hypogonadism and anti-cancer treatment. A number...